Insider Cluster (2 insiders) ·Filed Jun 16, 2026

ONMD

OneMedNet Corp
BULLISH
Impact 6/10
Horizonweeks Processed3mo ago
Insider cluster: 2 insiders, $121K total
Actionable Insight ▲ Bullish

The CEO and a director buying concurrently is a positive signal for a micro-cap stock. Monitor for upcoming news or catalysts (earnings, contract wins) that may have prompted the purchases. The small market cap and low liquidity warrant caution on position sizing.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
ONMD ▲ +33.01% at T+60d
LONG call ✓ call won +33.01% · α vs SPY +32.01% · entry $0.5011 → $0.6665
Entry anchored
Jun 15, 03:57 PM ET
via exchange tick
T+1d
+20.20%
call +20.20% · α +21.44%
$0.6023
settled 4mo ago
T+5d
+19.74%
call +19.74% · α +21.97%
$0.6000
settled 3mo ago
T+20d
+45.02%
call +45.02% · α +44.82%
$0.7267
settled 3mo ago
T+60d
+33.01%
call +33.01% · α +32.01%
$0.6665
settled 21d ago

Price Chart

Loading chart...

Executive Summary

CEO Aaron Green and director/10% owner Thomas Kosasa made open-market purchases totaling $121K over a 7-day window, representing 0.4% of ONMD's $30M market cap. This insider buying cluster signals confidence from top insiders at a micro-cap company, though the absolute dollar amount is modest.

Key Financial Metrics

Direction
buying
Total Value
$121.0K
Insiders
2

Key Facts

  • CEO Aaron Green purchased 55,622 shares for ~$31K at $0.54-$0.56/share
  • Director Thomas Kosasa purchased 158,730 shares for $100K at $0.63/share
  • Total insider buying of $121K represents 0.4% of ONMD's $30M market cap
  • All transactions were open-market purchases (no 10b5-1 plans indicated)

Financial Impact

Insider buying of $121K (0.4% of market cap) is modest in absolute terms but significant for a micro-cap company with limited float

insider ownershipmarket cap

Risk Factors

  • Micro-cap stock with low liquidity and high volatility
  • Insider buying amount is modest relative to market cap
  • No specific catalyst identified; buying may be pre-planned or opportunistic

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ONMD-1781604328587
7 reports for ONMD
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ONMD — sortable, filterable
TypeNow
Jul 24, 2026
10w ago
8-K
NEUTRAL ★ 2/10
$0.6059 $0.5901▼ −2.61%▼ −5.91%$5.39 (+789.59%)
Jul 13, 2026
11w ago
EFFECT
NEUTRAL ★ 3/10
$0.7457 $0.6600▼ −11.49%▼ −14.68%$5.39 (+622.81%)
Jun 17, 2026
15w ago
Insider Cluster
BULLISH ★ 6/10
$0.6023 $0.6901▲ +14.58%▲ +13.26%$5.39 (+794.90%)
Jun 16, 2026
15w ago
Insider Cluster
BULLISH ★ 6/10
$0.5011 $0.7267▲ +45.02%▲ +44.82%$5.39 (+975.63%)
Apr 6, 2026
25w ago
Press Release
BULLISH ★ 8/10
$0.9520 $1.05▲ +10.29%▲ +1.31%$5.39 (+466.18%)
Apr 1, 2026
26w ago
Press Release
NEUTRAL ★ 4/10
$0.8440 $1.08▲ +27.96%▲ +18.24%$5.39 (+538.63%)
Mar 18, 2026
28w ago
Press Release
MIXED ★ 5/10
$0.8190 $0.8870▲ +8.30%▲ +2.26%$5.39 (+558.12%)
Showing 7 of 7

US Market Status

Market Closed — Opens Mon (38h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 16, 2026